GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP) » Definitions » Valuation Rank

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Valuation Rank


View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Oxford Cannabinoid Technologies Holdings Valuation Rank Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP) » Definitions » Valuation Rank
Comparable Companies
LSE:IMM LSE:CIZ LSE:IXI LSE:BSFA LSE:APTA AQSE:PBX LSE:EVG LSE:ROQ AQSE:INC LSE:GENF OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
0CB:Germany
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Website
https://www.oxcantech.com
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.